NIST BMD Seminar: Next Gen COVID19 vaccines

Printer-friendly versionPrinter-friendly versionPDF versionPDF version
Event Type: 
Contact Person: 
Mike Tarlov
Event Info
Oct 4 2021 - 1:00pm to 2:00pm
Deborah H. Fuller, PhD
Speaker Affiliation: 
Professor, Department of Microbiology, University of Washington School of Medicine; Division Chief, Infectious Diseases and Translational Medicine, Washington National Primate Research Center
Event Description: 

Nucleic acid vaccines have emerged as the leading approach to combat the current COVID19 pandemic. However, there are still large regions in the world where vaccine distribution is sparse creating “vaccine deserts” where viral transmission and replication is occurring unchecked, increasing the likelihood of the emergence of a new variant of concern that could be resistant to current COVID19 vaccines. In addition, zoonotic transmission of a new betacoronavirus (CoV) remains a constant threat. The Fuller lab is developing next generation COVID19 DNA and RNA vaccine technologies that are stable at room temperature, can be self-administration and are capable of inducing long-lasting immunity not only against current circulating variants of concern but also, against the emergence of future variants and zoonotic outbreaks to prevent future pandemics.


Join Zoom Meeting

Meeting ID: 919 1674 5410
Passcode: 826708
One tap mobile
+13017158592,,91916745410# US (Washington DC)
+13126266799,,91916745410# US (Chicago)

Dial by your location
        +1 301 715 8592 US (Washington DC)
        +1 312 626 6799 US (Chicago)
        +1 929 436 2866 US (New York)
        +1 346 248 7799 US (Houston)
        +1 669 900 6833 US (San Jose)
        +1 253 215 8782 US (Tacoma)